AbbVie
ABBV
#26
Rank
HK$3.072 T
Marketcap
HK$1,738
Share price
-0.29%
Change (1 day)
33.85%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2025 (TTM): HK$10.55

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$10.52. In 2024 the company made an earnings per share (EPS) of HK$18.85 a decrease over its 2023 EPS that were of HK$21.39.

EPS history for AbbVie from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$10.55-44.02%
2024HK$18.85-11.86%
2023HK$21.39-58.95%
2022HK$52.112.49%
2021HK$50.85121.58%
2020HK$22.95-44.7%
2019HK$41.4945.84%
2018HK$28.459.72%
2017HK$25.93-9.54%
2016HK$28.6716.28%
2015HK$24.65184.1%
2014HK$8.68-57.15%
2013HK$20.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.39 27.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.12 119.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.72 1,417.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.43 863.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$50.75 382.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.55 712.95%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.99 166.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
HK$23.62 124.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$33.55 218.82%๐Ÿ‡บ๐Ÿ‡ธ USA